The Lancet Oncology
Journal providing information relevant to cancer specialists
The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.
Visit website: https://www.thelancet.com/journals/lanonc/home
See also: The Lancet - Medical journal covering general medicine
Details last updated 09-Nov-2019
The Lancet Oncology News
AI spots breast cancer as good as two radiologists
BBC - 02-Aug-2023
Use of AI supported screening can help reduce workloads and patient wait times
Read more...Galleri blood test: a step closer to early cancer detection
BBC - 02-Jun-2023
Offers promising results in the detection, and original site, of over 50 types of cancer in major NHS study
Read more...Cancer survival rates improving, but UK performing poorly
BBC - 12-Sep-2019
If there is an election soon, then maybe consider the parties' health policies as well as Brexit
Read more...Drug attacks cancers cells using trojan horse antibody
Independent - 08-Feb-2019
Novel mechanisms for attacking cancer cells are always good news
Read more...Cool your beverages to reduce risk of cancer
Harvard University - 06-Sep-2016
Nonalcoholic beverages consumed above 65° C (150° F) may contribute to the risk of esophageal can...
Read more...Prostate cancer drug choice improved with genetic analysis
Irish Medical Times - 16-Jul-2015
More than 5,000 patients with metastatic disease recruited from four large multi-centre global cl...
Read more...